Alzheimer's Association: Biomarkers across Neurodegenerative Diseases (BAND)- LOI

The main objective is to stimulate analyses across Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases to increase understanding of pathogenesis similarities and differences. The intent of this RFA is to analyze across existing data; biological samples are not available for use under this RFA. Funding from this program may support but is not limited to projects that aim to develop and/or advance innovative data models, biomarker discovery, assay standardization, genetic profiling, harmonize existing data set phenotypes, analyze cross-disease or longitudinal analyses of existing data, inclusion of other neurodegenerative diseases related to PD and AD, or imaging development.

Funding:  $150K for 2 years. (Direct and indirect costs- indirect costs 10%)

https://alz.org/research/for_researchers/grants/types-of-grants/partnership_funding_programs/biomarkers_across_neurodegenerative_diseases